Project Oncology®

177 Episoade

1. FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

   Publicat: 07.01.2018
2. CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

   Publicat: 23.10.2017
3. Pancreatic Cancer: The Hunt to Catch a Silent Killer

   Publicat: 12.08.2017
4. FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

   Publicat: 28.07.2017
5. FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

   Publicat: 25.07.2017
6. Linking p53 Variation to Breast Cancer Risk in African American Women

   Publicat: 19.06.2017
7. FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval

   Publicat: 30.05.2017
8. Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches

   Publicat: 23.05.2017
9. FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

   Publicat: 22.05.2017
10. FDA D.I.S.C.O.: Niraparib in Ovarian Cancer

    Publicat: 18.05.2017
11. Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer

    Publicat: 17.04.2017
12. Hot Topics in Breast Cancer Innovations

    Publicat: 06.02.2017
13. A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient

    Publicat: 02.02.2017
14. High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management

    Publicat: 20.04.2016
15. From Silent Killer to Treatable Disease: Improved Detection Methods for Ovarian Cancer

    Publicat: 07.03.2016
16. Are Practicing Ob-Gyn Oncologists on Your Speed Dial?

    Publicat: 08.02.2016
17. Nutrition & Breast Cancer Risk: Connecting the Dots with Emerging Evidence

    Publicat: 31.08.2015